Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, August 27, 2014 9:48:43 AM
bullish
$ORGS recent news/filings
## source: finance.yahoo.com
Mon, 25 Aug 2014 10:00:37 GMT ~ ORGENESIS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic
read full: http://biz.yahoo.com/e/140825/orgs8-k.html
*********************************************************
Thu, 07 Aug 2014 10:01:52 GMT ~ ORGENESIS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic
read full: http://biz.yahoo.com/e/140807/orgs8-k.html
*********************************************************
Tue, 05 Aug 2014 17:42:36 GMT ~ ORGENESIS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities
read full: http://biz.yahoo.com/e/140805/orgs8-k.html
*********************************************************
Mon, 04 Aug 2014 13:00:00 GMT ~ Scott Carmer Named as CEO of Orgenesis North America
[Marketwired] - Orgenesis Inc. , a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of industry veteran Scott Carmer as CEO of the company's North American ...
read full: http://finance.yahoo.com/news/scott-carmer-named-ceo-orgenesis-130000087.html
*********************************************************
Wed, 16 Jul 2014 17:04:08 GMT ~ ORGENESIS INC. Financials
read full: http://finance.yahoo.com/q/is?s=orgs
*********************************************************
$ORGS charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ORGS company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ORGS/company-info
Ticker: $ORGS
OTC Market Place: OTCQB
CIK code: 0001460602
Company name: Orgenesis, Inc.
Company website: http://www.orgenesis.com
Incorporated In: NV, USA
Business Description: Orgenesis (ORGS) is a development stage company with a novel therapeutic technology that employs a molecular and cellular approach directed at converting a patient's own liver cells into functional insulin producing cells, as a treatment for diabetes. The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk of transplant rejection. If successful, this could mean the end of diabetes, as we now know it. For more information visit: www.orgenesis.com.Less >>
$ORGS share structure
## source: otcmarkets.com
Market Value: $45,531,395 a/o Aug 26, 2014
Shares Outstanding: 54,791,089 a/o Jul 09, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$ORGS extra dd links
Company name: Orgenesis, Inc.
Company website: http://www.orgenesis.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ORGS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ORGS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ORGS+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/news - http://finance.yahoo.com/q/h?s=ORGS+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ORGS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ORGS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ORGS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Orgenesis%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Orgenesis%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Orgenesis%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.orgenesis.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.orgenesis.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.orgenesis.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ORGS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001460602&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ORGS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ORGS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ORGS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ORGS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ORGS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ORGS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ORGS+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ORGS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ORGS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ORGS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ORGS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ORGS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ORGS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ORGS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ORGS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ORGS
$ORGS DD Notes ~ http://www.ddnotesmaker.com/ORGS
Recent ORGS News
- Orgenesis Announces Reverse Stock Split • GlobeNewswire Inc. • 09/23/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 12:30:47 PM
- Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia • GlobeNewswire Inc. • 08/29/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 08:05:13 PM
- Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally • GlobeNewswire Inc. • 08/14/2024 12:30:00 PM
- Orgenesis Provides Second Quarter 2024 Business Update • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2024 03:25:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/14/2024 12:45:29 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/14/2024 04:15:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:05:26 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/06/2024 08:05:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 10:14:05 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/24/2024 01:16:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 12:00:31 PM
- Orgenesis Provides Business Update for the First Quarter of 2024 • GlobeNewswire Inc. • 05/21/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:01:42 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:01:20 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 07:28:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/06/2024 07:26:43 PM
- Orgenesis Provides Year End Business Update • GlobeNewswire Inc. • 04/15/2024 09:07:16 PM
- Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility • GlobeNewswire Inc. • 04/10/2024 04:00:00 PM
- Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference • GlobeNewswire Inc. • 03/18/2024 12:30:00 PM
- Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes • GlobeNewswire Inc. • 03/13/2024 12:30:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM